Search research articles
Contact Us
Filters
Showing results (141-150 of 300) with videos related to
Page
of 30
Sort By:
Leukemia & Lymphoma
|
July 9, 2019
Patients with diffuse large B-cell lymphoma requiring urgent treatment: its implication on trial design and interpretation
Kah Poh Loh, Andrea Baran, Christina Y Lee, et al.
Cancer
|
March 27, 2014
The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States
Loretta J Nastoupil, Rajni Sinha, Michelle Byrtek, et al.
Blood
|
November 10, 2023
Brentuximab vedotin with dacarbazine or nivolumab as frontline cHL therapy for older patients ineligible for chemotherapy
Jonathan W Friedberg, Rodolfo Bordoni, Dipti Patel-Donnelly, et al.
Cancer
|
March 22, 2012
Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare Study
Chadi Nabhan, Michelle Byrtek, Michael D Taylor, et al.
Journal of the National Cancer Institute
|
January 2, 2017
T-Cell Lymphoma: Recent Advances in Characterization and New Opportunities for Treatment
Carla Casulo, Owen O'Connor, Andrei Shustov, et al.
British Journal of Haematology
|
January 6, 2016
Outcomes following watchful waiting for stage II-IV follicular lymphoma patients in the modern era
Loretta J Nastoupil, Rajni Sinha, Michelle Byrtek, et al.
British Journal of Haematology
|
April 9, 2015
Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States
Chadi Nabhan, Michelle Byrtek, Ashish Rai, et al.
Blood
|
August 30, 2002
Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors
Andrea K Ng, M V Patricia Bernardo, Edie Weller, et al.
Blood
|
February 7, 2009
Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a "vaccinal effect" of rituximab
Shannon P Hilchey, Ollivier Hyrien, Tim R Mosmann, et al.
Leukemia & Lymphoma
|
September 30, 2014
Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States
Loretta J Nastoupil, Rajni Sinha, Michelle Byrtek, et al.
Page
of 30
Search research articles
Search
Showing results (141-150 of 300) with videos related to
Sort By:
Page
of 30
Leukemia & Lymphoma
|
July 9, 2019
Patients with diffuse large B-cell lymphoma requiring urgent treatment: its implication on trial design and interpretation
Kah Poh Loh, Andrea Baran, Christina Y Lee, et al.
Cancer
|
March 27, 2014
The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States
Loretta J Nastoupil, Rajni Sinha, Michelle Byrtek, et al.
Blood
|
November 10, 2023
Brentuximab vedotin with dacarbazine or nivolumab as frontline cHL therapy for older patients ineligible for chemotherapy
Jonathan W Friedberg, Rodolfo Bordoni, Dipti Patel-Donnelly, et al.
Cancer
|
March 22, 2012
Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare Study
Chadi Nabhan, Michelle Byrtek, Michael D Taylor, et al.
Journal of the National Cancer Institute
|
January 2, 2017
T-Cell Lymphoma: Recent Advances in Characterization and New Opportunities for Treatment
Carla Casulo, Owen O'Connor, Andrei Shustov, et al.
British Journal of Haematology
|
January 6, 2016
Outcomes following watchful waiting for stage II-IV follicular lymphoma patients in the modern era
Loretta J Nastoupil, Rajni Sinha, Michelle Byrtek, et al.
British Journal of Haematology
|
April 9, 2015
Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States
Chadi Nabhan, Michelle Byrtek, Ashish Rai, et al.
Blood
|
August 30, 2002
Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors
Andrea K Ng, M V Patricia Bernardo, Edie Weller, et al.
Blood
|
February 7, 2009
Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a "vaccinal effect" of rituximab
Shannon P Hilchey, Ollivier Hyrien, Tim R Mosmann, et al.
Leukemia & Lymphoma
|
September 30, 2014
Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States
Loretta J Nastoupil, Rajni Sinha, Michelle Byrtek, et al.
Page
of 30